Gartner Research

Standardization in an Era of Personalized Care: Challenges and Opportunities for IDN Pharmaceutical Supply Chains

Published: 27 January 2017

ID: G00324012

Analyst(s): Anita Vila-Parrish , Eric O'Daffer


Product proliferation and a shift to value-based care are creating the need for radical change in the IDN pharmaceutical supply chain. This research details how supply chain leaders responsible for IDNs can align cost-efficient business strategies with patient-centered care.

Table Of Contents
  • Impacts


Impacts and Recommendations

  • Supply chain leaders responsible for IDNs have had limited control over pharmacy supply chains, making it difficult for them to synchronize the end-to-end supply chain
  • A growing portfolio of products, estimated at 50% growth in SKUs over the past three to five years, along with an outmoded medication product classification system are restricting supply chain leaders from optimizing an IDN's supply chain strategy
  • IDN supply chain metrics are narrowly focused, limiting supply chain leaders' ability to measure the impact of pharmaceutical supply chain trade-offs on service, cost and patient outcomes
    • Define a Value-Driven Pharmaceutical Supply Chain
    • Link Supply Chain Capabilities and Clinical Operations

Gartner Recommended Reading

©2021 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.